Resultados da busca - Eytan Ben‐Ami
- Mostrando 1 - 9 resultados de 9
-
1
Nicotinamide Inhibits Vasculogenic Mimicry, an Alternative Vascularization Pathway Observed in Highly Aggressive Melanoma por Orit Itzhaki, Eyal Greenberg, Bruria Shalmon, Adva Kubi, Avraham J. Treves, Ronnie Shapira‐Frommer, Camilla Avivi, Rona Ortenberg, Eytan Ben‐Ami, Jacob Schachter, Michal J. Besser, Gal Markel
Publicado em 2013Artigo -
2
A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme por Gilli Galore-Haskel, Yael Nemlich, Eyal Greenberg, Shira Ashkenazi, Motti Hakim, Orit Itzhaki, Noa Shoshani, Ronnie Shapira-Fromer, Eytan Ben‐Ami, Efrat Ofek, Liat Anafi, Michal J. Besser, Jacob Schachter, Gal Markel
Publicado em 2015Artigo -
3
Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study por Eytan Ben‐Ami, Constance M. Barysauskas, Sarah Solomon, Kadija Tahlil, Rita Malley, Melissa Hohos, Kathleen Polson, Margaret Loucks, Mariano Severgnini, Tara Patel, Amy Cunningham, Scott J. Rodig, F. Stephen Hodi, Jeffrey A. Morgan, Priscilla Merriam, Andrew J. Wagner, Geoffrey I. Shapiro, Suzanne George
Publicado em 2017Artigo -
4
Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies por Michal J. Besser, Ronnie Shapira‐Frommer, Orit Itzhaki, Avraham J. Treves, Douglas Zippel, Daphna Levy, Adva Kubi, Noa Shoshani, Dragoslav Zikich, Yaara Ohayon, Daniel Ohayon, Bruria Shalmon, Gal Markel, Ronit Yerushalmi, Sara Apter, Alon Ben‐Nun, Eytan Ben‐Ami, Avichai Shimoni, Arnon Nagler, Jacob Schachter
Publicado em 2013Artigo -
5
Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kin... por Eytan Ben‐Ami, Constance M. Barysauskas, Margaret von Mehren, Michael C. Heinrich, C. L. Corless, James E. Butrynski, Jeffrey A. Morgan, Andrew J. Wagner, Edwin Choy, Jeffrey T. Yap, Annick D. Van den Abbeele, Sarah Solomon, Jonathan A. Fletcher, George D. Demetri, Stephen L. George
Publicado em 2016Artigo -
6
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors por Alexander Muik, Elena Garralda, Işıl Altıntaş, Friederike Gieseke, Ravit Geva, Eytan Ben‐Ami, Corinne Maurice‐Dror, Emiliano Calvo, Patricia LoRusso, Guzmán Alonso, María E. Rodríguez-Ruiz, Kristina B. Schoedel, Jordan M. Blum, Bianca Sänger, Theodora W. Salcedo, Saskia M. Burm, Eliana Stanganello, Dennis Verzijl, Fulvia Vascotto, Angelica Sette, Juliane Quinkhardt, Theo S. Plantinga, Aras Toker, Edward N. van den Brink, Mark Fereshteh, Mustafa Diken, David Satijn, Sebastian Kreiter, Esther C.W. Breij, Gaurav Bajaj, Eleni Lagkadinou, Kate Sasser, Özlem Türeci, Ulf Forssmann, Tahamtan Ahmadi, Uğur Şahin, Maria Jure‐Kunkel, Ignacio Melero
Publicado em 2022Artigo -
7
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network por Anna Maria Frezza, Tarek Assi, Salvatore Lo Vullo, Eytan Ben‐Ami, Armelle Dufresne, Kan Yonemori, Emi Noguchi, Brittany L. Siontis, Richard Ferraro, Paweł Teterycz, Florence Duffaud, Vinod Ravi, Bruno Vincenzi, Hans Gelderblom, Maria A. Pantaleo, Giacomo Giulio Baldi, Ingrid M.E. Desar, А. А. Феденко, Robert G. Maki, Robin L. Jones, Robert S. Benjamin, Jean‐Yves Blay, Akira Kawai, Mrinal M. Gounder, Alessandro Gronchi, Axel Le Cesne, Olivier Mir, Anna M. Czarnecka, Scott M. Schuetze, Andrew J. Wagner, Julien Adam, Marta Barisella, Marta Sbaraglia, Jason L. Hornick, Alexandra Meurgey, Luigi Mariani, Paolo G. Casali, Katherine A. Thornton, Silvia Stacchiotti
Publicado em 2019Artigo -
8
Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma por Anna Maria Frezza, Robin L. Jones, Salvatore Lo Vullo, Naofumi Asano, Francesca Lucibello, Eytan Ben‐Ami, Ravin Ratan, Paweł Teterycz, Kjetil Boye, Mehdi Brahmi, Emanuela Palmerini, А. А. Феденко, Bruno Vincenzi, Antonella Brunello, Ingrid M.E. Desar, Robert S. Benjamin, Jean‐Yves Blay, Javier Martín‐Broto, Paolo G. Casali, Hans Gelderblom, Giovanni Grignani, Alessandro Gronchi, Kirsten Sundby Hall, Olivier Mir, Piotr Rutkowski, Andrew J. Wagner, О. А. Анурова, Paola Collini, Angelo Paolo Dei Tos, Uta Flucke, Jason L. Hornick, Ingvild Lobmaier, Philippe Terrier, Piero Picci, Dominique Ranchère, Salvatore Lorenzo Renne, Marta Sbaraglia, Khin Thway, Michał Wągrodzki, Wei‐Lien Wang, Akihiko Yoshida, Luigi Mariani, Akira Kawai, Silvia Stacchiotti
Publicado em 2018Artigo -
9
A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine–Experienced Adults 50 Years of Age or Older (STRIDE-6) por Paul T. Scott, Miwa Haranaka, Jung‐Hyun Choi, Helen Stacey, Marc Dionne, David Greenberg, Carlos G. Grijalva, Walter A. Orenstein, Doreen Fernsler, Nancy Gallagher, T Zeng, Jianing Li, Heather Platt, Timothy J. Chapman, Karyn Davis, Marc Dionne, Peter Dzongowski, Ginette Girard, Guy Tellier, Richard Tytus, S. Jaffuel, Jean‐François Nicolas, Eytan Ben Ami, Daniele Bendayan, Yoseph Caraco, Michal Chowers, Mahmud Darawsha, Avivit Peer, Francesco Bruno Blasi, Antonella Castagna, Claudio Costantino, Domenico Martinelli, Miwa Haranaka, Makoto Yono, Jung‐Hyun Choi, Won Suk Choi, Dong‐Gun Lee, Jacob Lee, Hyejin Shi, Joon Young Song, Gustavo de Luíz Martinez, José María Echave-Sustaeta María-Tomé, Cristina Masuet‐Aumatell, Silvia Narejos Pérez, Anna Vilella Morató, Kuo‐Chin Huang, Yi-Ching Yang, David Butuk, Jose Francisco Cardona, Nizar Daboul, Thomas Fiel, Neil J. Fraser, George Hartley Freeman, S Geller, Charles Harper, William Johnston, Thomas Lenzmeier, Enrique Pelayo, Laura Porterfield, Kathryn R. Rigonan, Jeffrey B. Rosen, Helen L Stacey
Publicado em 2024Artigo
Ferramentas de busca:
Assuntos relacionados
Medicine
Cancer
Internal medicine
Biology
Oncology
Cancer research
Immunology
Immunotherapy
Chemotherapy
Clinical trial
Immune system
Melanoma
Anthracycline
Antibody
Biochemistry
Breast cancer
Gastroenterology
Gemcitabine
Gene
Genetics
In vitro
Ipilimumab
Pazopanib
Phases of clinical research
Sunitinib
Surgery
T cell
ADAR
Adoptive cell transfer
Adverse effect